Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,050 | -119,204 | -84,610 | -65,122 | -39,110 |
| Depreciation Amortization | -171 | 5,326 | 4,972 | 3,637 | 1,873 |
| Accounts receivable | -2,751 | 5,341 | 1,213 | -85,217 | 768 |
| Accounts payable and accrued liabilities | 198 | -1,225 | -288 | 836 | -1,132 |
| Other Working Capital | -24,411 | 104,405 | 84,840 | 4,863 | -5,223 |
| Other Operating Activity | 16,194 | 8,906 | 21,286 | 102,562 | 7,569 |
| Operating Cash Flow | $-60,991 | $3,549 | $27,413 | $-38,441 | $-35,255 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -942 | -7,858 | -4,491 | -3,753 | -1,553 |
| Purchase Of Investment | -52,764 | -216,671 | -114,498 | -14,938 | -10,994 |
| Sale Of Investment | 121,157 | 189,498 | 121,849 | 99,588 | 45,529 |
| Other Investing Activity | 0 | 9 | 0 | 0 | 0 |
| Investing Cash Flow | $67,451 | $-35,022 | $2,860 | $80,897 | $32,982 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,125 | -9,375 | -6,250 | -3,125 | 0 |
| Common Stock Issued | 11,237 | 56,538 | 41,192 | 8,777 | 180 |
| Other Financing Activity | 646 | 1,150 | 1,150 | 593 | 580 |
| Financing Cash Flow | $8,758 | $48,313 | $36,092 | $6,245 | $760 |
| Beginning Cash Position | 48,126 | 31,286 | 31,286 | 31,286 | 31,286 |
| End Cash Position | 63,344 | 48,126 | 97,651 | 79,987 | 29,773 |
| Net Cash Flow | $15,218 | $16,840 | $66,365 | $48,701 | $-1,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,991 | 3,549 | 27,413 | -38,441 | -35,255 |
| Capital Expenditure | -942 | -7,858 | -4,491 | -3,753 | -1,553 |
| Free Cash Flow | -61,933 | -4,309 | 22,922 | -42,194 | -36,808 |